A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Sickle Cell Disease

In brief

The purpose of this study is to determine whether ticagrelor is effective in reducing the number of days of pain, intensity of pain, and reducing the use of analgesics due to sickle cell disease

Key facts

Study ID
NCT02482298
Run by
AstraZeneca
People needed
87
Starts
2015-07-09
Expected to finish
2016-11-16
Last updated by the study team
2018-12-19

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.